Figure 1From: Health and economic impact of combining metformin with nateglinide to achieve glycemic control: Comparison of the lifetime costs of complications in the U.KSchematic representation of model (Reprinted with permission from Can J Diabetes. 2003; 27(1): 33–41).Back to article page